Pittsburgh biotech company wins funding for Covid-19 drug
July 07, 2020 at 10:54 AM EDT
CytoAgents received $250,000 from the Richard King Mellon Foundation to help develop its treatment for a side effect of the novel coronavirus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|